02329 GLORY HEALTH
- 0.052
- +0.002+4.00%
GLORY HEALTH News
Changes in US dollar bonds | Guorui Health GUOPRO 14.25 08/23/24, the price fell 20.548% to 5.800
The current price of GUOPRO 14.25 08/23/24, issued by Guorui Health on May 4, fell -20.548%, yield-%.
國瑞健康：2023年度報告
Changes in US dollar bonds | Guorui Health GUOPRO 14.25 08/23/24, the price fell by 21.429% to 5.500
The current price of GUOPRO 14.25 08/23/24, issued by Guorui Health on April 26, fell -21.429%, yield-%.
Changes in US dollar bonds | Guorui Health GUOPRO 14.25 08/23/24 prices rose 16.667% to 4.200
The current price of GUOPRO 14.25 08/23/24 issued by Guorui Health on April 10 increased +16.667% yield-% at the current price of 4.200.
Changes in US dollar bonds | Guorui Health GUOPRO 14.25 08/23/24, the price fell 10.811% to 6.600
The current price of GUOPRO 14.25 08/23/24, issued by Guorui Health on April 9, fell -10.811% with a yield of -10.811%.
國瑞健康：澄清公布
Glory Health Industry Shrinks Loss in 2023
Glory Health Industry (HKG:2329) recorded a decline in attributable loss for the year ended Dec. 31, 2023, to 564 million yuan from 912.8 million yuan in 2022, a Tuesday filing on the Hong Kong bourse
GLORY HEALTH: ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED DECEMBER 31,2023
Guorui Health (02329) announced 2023 results. Losses attributable to owners of about 564 million yuan narrowed by 38.2% year-on-year
According to the Zhitong Finance App, Guorui Health (02329) announced its 2023 results, with total revenue of about 2.506 billion yuan, a year-on-year decrease of 35.8%; loss attributable to company owners was about 564 million yuan, a year-on-year decrease of 38.2%; loss per share was 0.13 points. According to the announcement, the decrease in revenue during the reporting period was mainly due to a reduction in the completed delivery area of the property development sector and a decrease in sales.
GLORY HEALTH: Annual Report
Guorui Health (02329.HK) plans to hold a board meeting on March 28 to consider and approve the annual results
Glonghui, March 18, 丨 Guorui Health (02329.HK) announced that the company will hold a board meeting on March 28, 2024 (Thursday) to consider and approve the annual results and announcements of the company and its subsidiaries for the year ended 31 December 2023, and to consider the proposed payment of a final dividend (if any).
Guorui Health (02329.HK) appoints Lam Yuen-ling as company secretary and Hong Kong representative for receiving legal process documents
Glonghui, Feb. 8 | Guorui Health (02329.HK) announced that from February 7, 2024, Lam Yuen-ling has been appointed as the company secretary and authorized representative to receive and deliver legal process documents and notices in Hong Kong on behalf of the company in accordance with Part 16 of the Companies Ordinance, Chapter 622 of the Laws of Hong Kong.
Guorui Health (02329): Zhao Yuhong was appointed as Executive Director
Guorui Health (02329) announced that Dong Xueer, Hao Zhenhe, and Sun Xiaodong each intended to invest more time and energy...
Guorui Health (02329.HK) appoints Ming dynasty accountants as new auditors
Gelonghui, January 12 | Guorui Health (02329.HK) announced that the company has appointed an accountant from the Ming dynasty as the company's new auditor, effective January 12, 2024 to fill the vacancy at Dahua Ma Shiyun Certified Public Accountants Limited after his retirement. The term of office will end until the end of the next annual general meeting of shareholders of the company.
GLORY HEALTH: INTERIM REPORT 2023
Guorui Health (02329) released interim results. Loss attributable to shareholders of 267 million yuan decreased by 60.9% year-on-year
According to Zhitong Financial App, Guorui Health (02329) announced its interim results for the six months ended June 30, 2023. The group achieved total revenue of RMB 1,457 million (same unit below), a year-on-year decrease of 50.55%; losses attributable to company owners were 267 million yuan, a year-on-year decrease of 60.9%; and losses of 6 points per share. The contracted sales volume for the six months ended June 30, 2023 was 2,087 billion yuan, and the corresponding contracted construction area was about 165,900 square meters. The average sales price of signed contracts during the reporting period was 27875.3 yuan per square meter. As of 2023/6/3
GLORY HEALTH: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2023
Guorui Health (02329.HK) plans to hold a board meeting on August 31 to approve the interim results
GLONGHUI, August 22丨Guorui Health (02329.HK) announced that the company will hold a board meeting on August 31, 2023 (Thursday) to consider and approve (among other things) the unaudited interim results of the company and its subsidiaries for the six months ended June 30, 2023 and their publication, and to consider the payment of interim dividends (if any).
GLORY HEALTH: DATE OF BOARD MEETING
Glory Health Unit Gets More Time to Pay 1.3 Billion Yuan Loan
Glory Health Industry (HKG:2329) subsidiary Glory Xingye (Beijing) Investment reached an agreement with the Bank of Tianjin to extend the maturity date of its loans worth 1.33 billion yuan that were s
Analysis
Price Target
No Data
